The deal would hand Lundbeck a treatment for a series of rare brain disorders that could, by the company's estimates, become a blockbuster product.
Alzheimer's is a brain disease that causes memory loss and thinking problems. It gets worse over time and is the most common ...
Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to ...
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
A unique peek inside the human brain may help explain how it clears away waste like the kind that can build up and lead to ...
The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...
Supplements loaded with acetylcholine aim to increase its presence in the brain, potentially enhancing cognitive abilities and memory capacity ... in a cGMP and FDA-registered facility, which ...
An Army-developed tool uses a drop of blood to diagnose traumatic brain injuries and could help medics rule out evacuations ...
Christopoulos, Dean of the Faculty of Pharmaceutical Sciences at Monash University, is at the centre of a significant ...
Dr. Kimberly Doyle from Baylor Scott & White shares valuable tips to ward off cognitive decline and keep your mind sharp as ...
Shasta County is pushing a healthy brain initiative, offering free classes to older adults who have Alzheimer's disease ...